PTH1-34 Alleviates Radiotherapy-induced Local Bone Loss by Improving Osteoblast and Osteocyte Survival

Cancer radiotherapy is often complicated by a spectrum of changes in the neighboring bone from mild osteopenia to osteoradionecrosis. We previously reported that parathyroid hormone (PTH, 1–34), an anabolic agent for osteoporosis, reversed bone structural deterioration caused by multiple microcomput...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Chandra, Abhishek, Lin, Tiao, Tribble, Mary Beth, Zhu, Ji, Altman, Allison R., Tseng, Weiju, Zhang, Yejia, Akintoye, Sunday O., Cengel, Keith, Liu, X. Sherry, Qin, Ling
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2014
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4154509/
https://ncbi.nlm.nih.gov/pubmed/24998454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bone.2014.06.030
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak